Skip to content

Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle

Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02873793
Acronym
SEMINOMES
Enrollment
15
Registered
2016-08-22
Start date
2015-04-30
Completion date
Unknown
Last updated
2016-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Germinal Cancers of the Testicle

Brief summary

By analogy with the mouse, the activity of control pathways for transposable elements (TE) in foetal primordial germinal cells could prove to be a determinant for fertility in adulthood in humans. Moreover, defects in the control of transposable elements (TE) could also contribute to the aetiology of germinal testicular cancer, by inducing chromosomal instability and tumorigenesis. In this context, the aim is to analyse a specific type of adult germinal testicular cancers, seminomas. Directly related to our research interest, the histological, transcriptomic and epigenetic features of theses adult tumours are reminiscent of germinal cells normally present in foetuses. The investigator postulates that these similarities could also extend to the biology of transposable elements (TE), and in particular to the initiation of the control of these elements. The management of seminomas requires surgery, orchiectomy, which consists of the total excision of the affected testicles. Using high-resolution high-throughput sequencing techniques, we propose to analyse the control pathways of transposable elements (TE) in tumour samples harvested from surgical pieces in comparison with adjacent healthy tissue. The results obtained in these tumour samples will be compared with those in normal foetal gonad samples.

Interventions

GENETICExtraction of total RNA from healthy and tumour tissues

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* men who have provided oral consent * men with germinal testicular cancer with negative or low serum markers (Alpha Foeto Protein AFP and Human Chorionic Gonadotrophin hCG), indicators of a seminomatous-type tumour * men who have undergone orchiectomy (total excision of the affected testicle) * confirmation of the diagnosis of seminomatous or non-seminomatous type by histology of the surgical piece * absence of hepatitis B or C or infection with human immunodeficiency virus (HIV).

Exclusion criteria

* men without national health insurance cover * Adults under guardianship

Design outcomes

Primary

MeasureTime frameDescription
The role of Transposable Element in tumorigenesis seminomas adultsthrough the study completion up to 36 monthsTranscriptomic analysis of adult seminomas

Countries

France

Contacts

Primary ContactPatricia FAUQUE
Patricia.fauque@chu-dijon.fr03.80.29.50. 31

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026